Oslo, Norway

Ranveig Braathen

This inventor holds 1 USPTO granted patent. Top assignee: University of Oslo. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ranveig Braathen. Retrieved from https://idiyas.com/inventor/ranveig-braathen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ranveig Braathen

Introduction

Ranveig Braathen is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of vaccine technology. His work focuses on developing innovative solutions that enhance vaccine efficacy and targeting.

Latest Patents

Ranveig Braathen holds a patent for vaccine molecules. This technology relates to vaccines, particularly compositions, methods, and uses of heterodimer vaccine molecules. These molecules are formed from monomers that comprise a targeting unit and a variant antigenic unit, which are joined by heterodimerization units. This advancement has the potential to improve vaccine development and application.

Career Highlights

Braathen is affiliated with the University of Oslo, where he conducts research and development in the field of immunology. His work has garnered attention for its innovative approach to vaccine design. He is dedicated to advancing scientific knowledge and improving public health through his inventions.

Collaborations

Ranveig Braathen collaborates with Bjarne Bogen, a fellow researcher. Their partnership enhances the research efforts at the University of Oslo and contributes to the advancement of vaccine technology.

Conclusion

Ranveig Braathen's contributions to vaccine technology exemplify the importance of innovation in the field of medicine. His work not only advances scientific understanding but also has the potential to impact public health positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…